274 related articles for article (PubMed ID: 23637920)
1. GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.
Taichman RS; Patel LR; Bedenis R; Wang J; Weidner S; Schumann T; Yumoto K; Berry JE; Shiozawa Y; Pienta KJ
PLoS One; 2013; 8(4):e61873. PubMed ID: 23637920
[TBL] [Abstract][Full Text] [Related]
2. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS
Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
Mishra A; Wang J; Shiozawa Y; McGee S; Kim J; Jung Y; Joseph J; Berry JE; Havens A; Pienta KJ; Taichman RS
Mol Cancer Res; 2012 Jun; 10(6):703-12. PubMed ID: 22516347
[TBL] [Abstract][Full Text] [Related]
4. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.
Yumoto K; Eber MR; Wang J; Cackowski FC; Decker AM; Lee E; Nobre AR; Aguirre-Ghiso JA; Jung Y; Taichman RS
Sci Rep; 2016 Nov; 6():36520. PubMed ID: 27819283
[TBL] [Abstract][Full Text] [Related]
5. AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.
Axelrod HD; Valkenburg KC; Amend SR; Hicks JL; Parsana P; Torga G; DeMarzo AM; Pienta KJ
Mol Cancer Res; 2019 Feb; 17(2):356-369. PubMed ID: 30291220
[TBL] [Abstract][Full Text] [Related]
6. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
[TBL] [Abstract][Full Text] [Related]
7. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.
Dantas-Barbosa C; Lesluyes T; Loarer FL; Chibon F; Treilleux I; Coindre JM; Meeus P; Brahmi M; Bally O; Ray-Coquard I; Sunyach MP; Cesne AL; Mir O; Bonvalot S; Toulmonde M; Italiano A; Saintigny P; Jean-Denis M; Ducimetiere F; Ranchere D; El Sayadi H; Alberti L; Blay JY
Br J Cancer; 2017 Dec; 117(12):1787-1797. PubMed ID: 29024938
[TBL] [Abstract][Full Text] [Related]
8. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.
Waizenegger JS; Ben-Batalla I; Weinhold N; Meissner T; Wroblewski M; Janning M; Riecken K; Binder M; Atanackovic D; Taipaleenmaeki H; Schewe D; Sawall S; Gensch V; Cubas-Cordova M; Seckinger A; Fiedler W; Hesse E; Kröger N; Fehse B; Hose D; Klein B; Raab MS; Pantel K; Bokemeyer C; Loges S
Leukemia; 2015 Mar; 29(3):696-704. PubMed ID: 25102945
[TBL] [Abstract][Full Text] [Related]
9. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
[TBL] [Abstract][Full Text] [Related]
10. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
[TBL] [Abstract][Full Text] [Related]
11. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.
Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439
[TBL] [Abstract][Full Text] [Related]
12. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
[TBL] [Abstract][Full Text] [Related]
13. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.
Shiozawa Y; Pedersen EA; Patel LR; Ziegler AM; Havens AM; Jung Y; Wang J; Zalucha S; Loberg RD; Pienta KJ; Taichman RS
Neoplasia; 2010 Feb; 12(2):116-27. PubMed ID: 20126470
[TBL] [Abstract][Full Text] [Related]
14. Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor.
Sainaghi PP; Castello L; Bergamasco L; Galletti M; Bellosta P; Avanzi GC
J Cell Physiol; 2005 Jul; 204(1):36-44. PubMed ID: 15605394
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
[TBL] [Abstract][Full Text] [Related]
16. Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer.
Avilla E; Guarino V; Visciano C; Liotti F; Svelto M; Krishnamoorthy G; Franco R; Melillo RM
Cancer Res; 2011 Mar; 71(5):1792-804. PubMed ID: 21343401
[TBL] [Abstract][Full Text] [Related]
17. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
Elife; 2014 Sep; 3():. PubMed ID: 25265470
[TBL] [Abstract][Full Text] [Related]
18. Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas.
el Sayadi H; Pissaloux D; Alberti L; Tabone-Eglinger S; Ranchere D; Decouvelaere AV; Tabone E; Ray-Coquard I; Caux C; Fayette J; Blay JY
Target Oncol; 2013 Dec; 8(4):261-9. PubMed ID: 23354874
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies.
Kariolis MS; Miao YR; Diep A; Nash SE; Olcina MM; Jiang D; Jones DS; Kapur S; Mathews II; Koong AC; Rankin EB; Cochran JR; Giaccia AJ
J Clin Invest; 2017 Jan; 127(1):183-198. PubMed ID: 27893463
[TBL] [Abstract][Full Text] [Related]
20. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling.
Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F
Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
